✦ LIBER ✦
KRAS or BRAF mutation status is a useful predictor of sensitivity to MEK inhibition in ovarian cancer
✍ Scribed by Nakayama, N; Nakayama, K; Yeasmin, S; Ishibashi, M; Katagiri, A; Iida, K; Fukumoto, M; Miyazaki, K
- Book ID
- 109999874
- Publisher
- Nature Publishing Group
- Year
- 2008
- Tongue
- English
- Weight
- 270 KB
- Volume
- 99
- Category
- Article
- ISSN
- 0007-0920
No coin nor oath required. For personal study only.